2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Reliability of Transcutaneous Bilirubin Measurement According to the Skin Colour of NewbornsBrain Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Hyperbilirubinemia, Neonatal, Infant, Newborn, Diseases, Jaundice, Neonatal, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bilirubin encephalopathy, brain disorder, central nervous system disorder, fetal erythroblastosis, hematologic disorder, hyperbilirubinemia, immune system disorder, metabolic disease, nervous system disorderNot yet recruitingNot stated2026-01-02NCT07315126
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) AdministrationBrain Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, Nutritional and Metabolic Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Premature Birth, Urogenital Diseases, bilirubin encephalopathy, brain disorder, central nervous system disorder, fetal erythroblastosis, hematologic disorder, hyperbilirubinemia, immune system disorder, metabolic disease, nervous system disorder, pregnancy disorderActive, not recruitingPhase 22025-11-28NCT04584983